RecruitingNCT06030752

WMT for Autism Spectrum Disorder (ASD)

Washed Microbiota Transplantation (WMT) for Autism Spectrum Disorder (ASD)

Sponsor

The Second Hospital of Nanjing Medical University

Enrollment

80 participants

Start Date

Sep 20, 2023

Study Type

OBSERVATIONAL

Conditions

Autism Spectrum Disorder

Summary

Autism Spectrum Disorder (ASD) is a group of serious neurodevelopmental disorders. A significant comorbidity exists between ADHD and ASD: 30%-50% of individuals with ASD exhibit ADHD symptoms, and two-thirds with ADHD show ASD traits. Intestinal microbial disturbance is common in children with ASD. A great deal of evidence shows that intestinal microbes can influence the brain to play its role through "gut-brain-microbiota axis". We intend to explore the role of Washed Microbiota Transplantation in improving symptoms of children in ASD with or without ADHD; To study the potential etiological mechanism of WMT for the neurodevelopmental disorders.

Eligibility

Min Age: 3 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Washed Microbiota Transplantation for people with autism spectrum disorder. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 3 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.